Editor’s note, March 20, 2020: When we published Tweets of Note yesterday, we were unaware of health care economist’s Rena Conti’s March 14 reply to a critic’s tweet the same day. We have added it to this web version of
…Category: Federal
For Now, HRSA Doesn’t Plan to Change Its April 340B Registration Period
With health care providers bracing for COVID-19’s full force, the Health Resources and Services Administration (HRSA) at this time does not plan
…HRSA Tells COVID-19 Responders Concerned About 340B Compliance to Contact it Directly
The Health Resources and Services Administration (HRSA) is advising health care providers concerned about whether
…Congressional Medicare Advisers Say 340B Has Minor Effect on Cancer Drug Spending and Patient Cost-Sharing
Do 340B drug discounts induce hospitals to furnish more-expensive drugs to treat cancer than they otherwise would, raising patients’ coinsurance obligations and the cost of
…Editor’s note: The Medicare Payment Advisory Commission (MedPAC) is expected to report to Congress tomorrow that 340B’s effects on Medicare Part B beneficiaries’ cost sharing is likely small and varied across patients. We’ll publish an article about the findings and
…Hospital Groups to OMB: Quash 340B Hospital Drug Acquisition Cost Survey
Groups representing 340B hospitals urged the White House yesterday to quash a planned survey due to
…DOJ Says Mallinckrodt Owes Medicaid Hundreds of Millions in Rebates, but Is Silent About 340B Overcharges
The U.S. Justice Department is suing drug manufacturer Mallinckrodt for allegedly
…340B Providers Could Face Drug Access Challenges Due to Coronavirus
In theory, federal law and 340B program guidance should protect 340B entities from shouldering an unfair
…Editor’s Note: The 340B Report team is working hard on a special report on key developments from the 340B Coalition Winter Conference Feb. 10-12 in San Diego. We do not plan to publish this Thursday’s edition. Expect to see a detailed
…Drug manufacturers are doing a better job of providing the Health Resources and Services Administration (HRSA) with timely and accurate data needed to verify their 340B ceiling prices, the head of the federal 340B drug pricing program indicated today. Nonetheless,
…